The Uncovered Role of Interferons in Sepsis: From Pathogenesis to Precision Immunotherapy
Seminars in Respiratory and Critical Care Medicine · 14.08.2026
DOI: 10.1055/a-2930-7367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 14.08.2026. Verfasst von Caroline Neumann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jena University Hospital, Department of Anesthesiology and Intensive Care Medicine, Germany, Jena.
Themen: Sepsis
Abstract (Originalsprache)
AbstractSepsis is a life-threatening syndrome characterized by a dysregulated host response to infection resulting in organ dysfunction. While traditional paradigms have emphasized proinflammatory cytokines, such as tumor necrosis factor-α and interleukin-1β, interferons (IFNs) are increasingly recognized as critical yet underexplored mediators of sepsis pathobiology. IFNs are central regulators of innate and adaptive immunity and have emerged as key mediators of the immune alterations observed during sepsis. Type I IFNs (IFN-α/β), type II IFN (IFN-γ), and type III IFNs exert pleiotropic effects on immune activation, pathogen clearance, endothelial function, immunometabolism, and tissue injury. While early IFN responses support antimicrobial defense, sustained or dysregulated signaling contributes to hyperinflammation, endothelial dysfunction, immune exhaustion, coagulopathy, and multiorgan failure. Increasing evidence from experimental models and clinical studies suggests that IFN activity differs substantially among septic patients and may define biologically distinct immune endotypes. IFN-stimulated gene signatures and IFN-related biomarkers therefore represent promising tools for patient stratification and precision immunotherapy. This review summarizes the biology of IFNs relevant to sepsis, their role across different disease phases, their contribution to organ dysfunction, and emerging therapeutic strategies targeting IFN pathways. Current evidence supports a shift toward biomarker-guided and phase-specific immunomodulation aimed at restoring immune homeostasis while minimizing harmful inflammation.
Autor:innen und Institutionen
- Jena University Hospital, Department of Anesthesiology and Intensive Care Medicine, Germany, Jena.
- Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, CHU Nantes, Pays de la Loire, France, Nantes.
- Service d'Anesthesie Réanimation, Nantes Université, INSERM, CHU Nantes, Pays de la Loire, France, Nantes.
ORCID-Profile: Caroline Neumann
Zitieren
APA
Neumann, C., Poulain, C., Roquilly, A., & Bauer, M. (2026). The Uncovered Role of Interferons in Sepsis: From Pathogenesis to Precision Immunotherapy. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/a-2930-7367
Vancouver
Neumann C, Poulain C, Roquilly A, Bauer M. The Uncovered Role of Interferons in Sepsis: From Pathogenesis to Precision Immunotherapy. Seminars in Respiratory and Critical Care Medicine. 2026. doi:10.1055/a-2930-7367
BibTeX
@article{Neumann2026,
author = {Neumann, Caroline and Poulain, Cecile and Roquilly, Antoine and Bauer, Michael},
title = {The Uncovered Role of Interferons in Sepsis: From Pathogenesis to Precision Immunotherapy},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2026},
doi = {10.1055/a-2930-7367}
}
EUVIMED